Breast Hematoma

Total Page：16

File Type：pdf, Size：1020Kb

For more information please call your provider. edithsanford.org Breast Hematoma 011004-00221 PE 8/21 Copyright©2015 Sanford. What Is a Hematoma? After Two Days – Start Using Heat A hematoma (hee-mah-toe-mah) is a collection of blood under the skin. Some After 48 hours, if the swelling has gone women may get a hematoma at the site down, apply gentle heat with warm wet of a breast biopsy. A hematoma is similar towels, a hot water bottle, or a heating to a deep bruise. pad. The heat helps the blood to absorb. Treatment for a Hematoma • Apply heat for 20 minutes at a time. Most hematomas will heal on their own. • Use heat 2 or 3 times each day. Healing may take from 4 to 6 weeks or Heat can cause swelling. After using heat, longer. Very large hematomas might have you may notice swelling in the tissue to be surgically drained. around the hematoma. You can use ice Home Treatment – after the heat to decrease that swelling. Start With Ice About Pain If you get a hematoma, place ice on the Hematomas often cause some pain. area to control the swelling for the first You may try: 48 hours: • Taking Acetaminophen products, • Apply ice for 20-30 minutes at such as Tylenol. See the package a time. instructions for correct dose. • Use ice 3 or more times a day. • Wearing a supportive bra. • Do not apply the ice directly to About Infection the skin. Wrap ice in a towel or other cloth. The pool of blood in a hematoma can become infected. Please call your primary • Do not do things that might care provider or surgeon if you notice any increase swelling. For example, of these signs: do not use hot packs, heating pads, or take a warm bath. • Breast is warm to the touch • Breast looks red • Swelling increases • Fever of 101 degrees Fahrenheit or more • Increased pain • Colored drainage coming from the biopsy site.

Copy Link

Recommended publications

Unresolved, Atraumatic Breast Hematoma: Post-Irradiation Or Secondary Breast Angiosarcoma
Breast Disease 33 (2011/2012) 139142 139 DOI 10.3233/BD-2012-0331 IOS Press Case Report Unresolved, atraumatic breast hematoma: Post-irradiation or secondary breast angiosarcoma Glenn Hanna, Samuel J. Lin, Michael D. Wertheimer and Ranjna Sharma Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Department of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Abstract. Post-irradiation or secondary angiosarcoma of the breast was rst described in the 1980s in patients treated with breast conserving therapy for cancer. The primary management of radiation-induced breast angiosarcoma has focused on surgical resection with an emphasis on achieving negative tumor margins. While surgery remains a key component of treatment, novel therapeutic approaches have surfaced. Despite such advances in treatment, prognosis remains poor. Keywords: Breast cancer, breast conservation therapy, secondary angiosarcoma 1. Clinical scenario amination showed the left breast to be larger than the right, with a 10 15cm areaofa clinicalhematomalo- A 64-year-old post-menopausal Caucasian female cated in the superior and inferior outer quadrants. The presented to our institution with a seven month history overlying skin was hemorrhagic, necrotic and had in- of an unresolved left breast hematoma. Of note, she durated features with areas of active bleeding. Initially, had a history of left breast inltrating ductal carcinoma no discrete underlying mass was identied on physical that was Her-2/Neu negative with estrogen and proges- examination. Areas of peau de orange surrounded the terone receptor positivity seven years prior. She had lesion. She had no palpable lymphadenopathy.
[Show full text]
Massachusetts Breastfeeding Resource Guide
Massachusetts Breastfeeding Resource Guide 2008 Edition © 254 Conant Road Weston, MA 02493 781 893-3553 Fax 781 893-8608 www.massbfc.org Massachusetts Breastfeeding Coalition Leadership Chair Board Member Melissa Bartick, MD, MS Lauren Hanley, MD Treasurer Board Member Gwen MacCaughey Marsha Walker, RN, IBCLC NABA, Lactation Associates Clerk Xena Grossman, RD, MPH Board Member Anne Merewood, MPH, IBCLC Board Member Lucia Jenkins, RN, IBCLC La Leche League of MA RI VT 10th edition (2008) Compiled and edited by Rachel Colchamiro, MPH, RD, LDN, CLC and Jan Peabody Cover artwork courtesy of Peter Kuper Funding for the printing and distribution of the Massachusetts Breastfeeding Resource Guide is provided by the Massachusetts Department of Public Health-Bureau of Family and Community Health, Nutrition Division. Permission is granted to photocopy this guide except for the three reprinted articles from the American Academy of Pediatrics and two articles from the American Academy of Family Physicians. Adapted from the Philadelphia Breastfeeding Resource Handbook. hhhhhhhhhhhhhhhhhhhhTable of Contents Organizational statements on breastfeeding…………………………………………………………….2 Breastfeeding and the Use of Human Milk, American Academy of Pediatrics…………………….6 Breastfeeding Position Paper, American Academy of Family Physicians……………………...…19 Breastfeeding initiatives………………………...……………………………………………………...…37 Breastfeeding support and services…………………………………………...………………...…....…39 La Leche League International leaders………….…………………………………………………...….40 Lactation consultants………………………………………………………………………………….…..44
[Show full text]
Bruise, Contusion & Ecchymosis Conventions
Bruise, Contusion and Ecchymosis MedDRA Proactivity Proposal Implementation MedDRA Version 16.0 I. MSSO Recognized Definitions of Concepts and Terms The MSSO has designated Dorland’s Illustrated Medical Dictionary as the standard reference for medical definitions. The following definitions are cited from Dorland’s 27th edition: Bruise – A superficial injury produced by impact without laceration; a contusion Contusion – A bruise; an injury of a part without a break in the skin Ecchymosis – A small hemorrhagic spot, larger than a petechia, in the skin or mucous membrane forming a nonelevated, rounded or irregular, blue or purplish patch. Hematoma – A localized collection of blood, usually clotted, in an organ, space, or tissue, due to a break in the wall of a blood vessel. Hemorrhage – The escape of blood from the vessels; bleeding. Petechia – A pinpoint, non-raised, perfectly round, purplish red spot caused by intradermal or submucous hemorrhage. Additional comments regarding the definitions: Bruise and contusion are synonymous, and are often used in a colloquial context. Bruise and contusion are each considered a result of injury. Bruise and contusion have been used to describe minor hemorrhage within tissue, where traumatized blood vessels leak blood into the interstitial space. Commonly, capillaries and sometimes venules are injured within skin, subcutaneous tissue, muscle, or bone. In addition to trauma, the terms bruise, ecchymosis, and to a lesser extent, contusion, have also been used as clinical signs of disorders of platelet function, coagulopathies, venous congestion, allergic reactions, etc. Hemorrhage may be used to describe blood escaping from vessels and retained in the interstitial space, and perhaps more commonly, to describe the escape of blood from vessels, and flowing freely external to the tissues.
[Show full text]
The Thoracic Radiologist's Guide to the Breast
The Thoracic Radiologist’s Guide to the Breast Gurpriya Gupta MD, Stacy Ries, DO, Jillian Krauss MD, Sayf Al-Katib MD, and Michael Farah MD 1: Beaumont Health System, Royal Oak MI Learning Objectives T o recognize normal CT appearance of breast tissue as CT may often provide the first images of the breast ⦿ To identify CT cross-sectional imaging appearance of benign and malignant breast processes in females and males ⦿ To become familiar with expected cross-sectional imaging appearance of the post-operative breast and recognize post-operative complications ⦿ To discuss the potential advantages of CT evaluation of the breast and encourage accurate description of findings for more valuable reporting ⦿ DisclosureDisclosures The authors of this educational exhibit have no significant financial disclosures to make. Introduction • Increased utilization of CT imaging has led to increased detection of incidental breast lesions • CT may be the first evaluation of the breast • Breast findings may easily be missed or not appropriately managed • 2003 study evaluating MDCT perform on 149 women with 173 breast lesions (Inoue et al) • Features predictive of malignancy: irregular margins, irregular shape, and rim enhancement • 2010 study with 78 incidental breast lesions on CT (Moyle et al) • Best morphological predictors of malignancy: spiculation and irregularity • Calcification patterns were found to be “diagnostically unhelpful” • Limited literature regarding imaging features for benign breast findings on CT. • Therefore, in the absence of long-term
[Show full text]
Immune Thrombocytopenic Purpura in a Twin Girl Revealed by a Traumatic Injury in Parakou (North Benin)
Immune thrombocytopenic purpura in a twin girl revealed by a traumatic injury in parakou (North Benin) Adedemy JD 1*, Noudamadjo A 1, Kpanidja G 1, Agossou J 1, Agbeille Mohamed F 1, Dovonou CA 2 1 Mother and Child Department, Parakou Teaching Hospital, Republic of Benin, and Faculty of Medicine, University of Parakou West Africa 2 Department of Medicine, Parakou Teaching Hospital, and Faculty of Medicine, University of Parakou, West Africa Abstract Background: ITP seems to be rare but in tropical settings thrombocytopenia is often encountered among children. Objective: Authors through this case report are putting emphasy on the diagnosis and management of ITP in a 4 year old twin girl admitted in the pediatric emergency ward for hematuria and bleeding from various origins seen in the context of a domestic trauma. Results: The various clinical signs have been analyzed to confirm ITP through exclusion of other possible health conditions. The management of ITP depend on the severity of clinical signs and in some cases the situations can be life threatening. In this case report, Blood transfusion and corticosteroids were the main treatment tools. The hospital stay was about 47 days and an ambulatory follow up was conducted for almost 6 months. Conclusion: In the context of various bleeding disorders, hematuria and thrombocytopenia, autoimmune thrombocytopenia in a twin girl was revealed by a domestic trauma. Citation: Adedemy JD, Noudamadjo A, Kpanidja G, Agossou J, Agbeille MF, Dovonou CA (2019) Immune Thrombocytopenic Purpura in a twin girl revealed by a traumatic injury in Parakou (North Benin). Adv Pediatr Res 6:27.
[Show full text]
R2P2 Resident Radpath .Pptx
Clues You Can Use: Core Breast Breast Imaging Division March 2018 BI-RADS® Assessment Categories o Assessments are divided into incomplete Category 0 and final assessment categories Categories 1-6 o Overall assessment based on the most worrisome finding or the need for immediate additional evaluation o Screening mammograms may be assigned Category 0,1,2 BI-RADS® Assessment Categories o BI-RADS® Category 0: INCOMPLETE - NEED ADDITIONAL IMAGING EVALUATION AND/OR PRIOR MAMMOGRAMS FOR COMPARISON o BI-RADS® Category 1: NEGATIVE o BI-RADS® Category 2: BENIGN o BI-RADS® Category 3: PROBABLY BENIGN o BI-RADS® Category 4: SUSPICIOUS o BI-RADS® Category 5: HIGHLY SUGGESTIVE OF MALIGNANCY o BI-RADS® Category 6: KNOWN BIOPSY-PROVEN MALIGNANCY Management Recommendations o Management recommendations on a per Assessment basis o Wording emphasizes recall, routine mammography screening, tissue diagnosis, surgical excision o Management recommended wording for tissue diagnosis is: “Biopsy should be performed in the absence of clinical contraindications.” o Management recommended wording for BI-RADS® 6 is : “Surgical excision when clinically appropriate.” o Category 0: INCOMPLETE - NEED ADDITIONAL IMAGING EVALUATION AND/OR PRIOR MAMMOGRAMS FOR COMPARISON Recall for additional imaging and/or comparison with prior examinations o Category 1: NEGATIVE Routine mammography screening o Category 2: BENIGN Routine mammography screening o Category 3: PROBABLY BENIGN Short interval 6 month follow-up OR continued surveillance o Category 4: SUSPICIOUS ABNORMALITY Biopsy
[Show full text]
How Significant Is Bleeding in Antiphospholipid Antibody
Treatment of Anti-Phospholipid Syndrome and Prothrombin Deficiency with Plasma Exchange Lowell Tilzer KU Medical Center Department of Pathology & Lab Medicine Case 72 YEARS OLD FEMALE PRESENTED TO KUMC WITH BLEEDING FOLLOWING ROUTINE HEMORRHOIDECTOMY SURGERY Past Medical History • Surgeries: Bilateral tubal ligation, appendectomy, partial hysterectomy, bilateral bunion surgery – No bleeding complications • 2008: Presented to ER with chest pain – Incidentally found prolonged PT and PTT + Lupus anticoagulant and anticardiolipin antibodies • 2009: Melanotic stool with severe anemia (Hb 4) – Blood transfusion (>10 units) – Attributed to long-term use of Aspirin Brief course Initial Work-up Reported Normal Test Value Range PT/INR 2.2 (HIGH) 0.8-1.2 PTT 87.4 (HIGH) 24.0-40.0 PT mixing study @ 60 mins 1.5 (HIGH) PTT mixing study @ 60 mins 82.8 (HIGH) Factor 2 assay 10% (LOW) 50-150% Factor 5 assay 78% 50-150% Factor 7 assay 153% (HIGH) 50-150% Factor 8 assay 235% (HIGH) 50-150% Factor 10 assay 68% 50-150% 300 Linear dilutions 250 200 150 100 % Normal control 50 0 Factor 2 Factor 5 Factor 7 Factor 8 Factor 10 Additional coagulation study Test Result Interpretation dRVVT Prolonged Lupus anticoagulant Abs Hexagonal Lupus Positive Lupus anticoagulant Abs anticoagulant Anti-b2 GPI IgG Positive Anti-b2 GPI IgM Positive Support APS diagnosis Anti-cardiolipin IgG Positive Anti-cardiolipin IgM Positive There is NO Factor 2 inhibitor, therefore previous result of low Factor 2 inhibitor <0.4 BU Factor 2 level was due to lupus (activity-based) anticoagulant Abs against phospholipids in the assay. Algorithm for Screening tests (PT/INR, aPTT) coagulopathies Mixing study Heparin, DTI PL dependent assays (aPTT or dRVVT + Hexa) PTT PT PT PTT LA+ Factor LA- Intrinsic Common Extrinsic inhibitors pathway pathway pathway Revised Criteria for Antiphospholipid Syndrome (APS) (Sydney Criteria) APS: ≥ 1 Laboratory Criteria AND ≥ 1 Clinical Criteria • Laboratory Criteria: “≥ 2 occasions 3 months apart” 1.
[Show full text]
Intracranial Haemorrhage in a 26 Year-Old Woman with Idiopathic Thrombocytopenic Purpura
Postgraduate Medical Journal (1987) 63, 781-783 Postgrad Med J: first published as 10.1136/pgmj.63.743.781 on 1 September 1987. Downloaded from Intracranial haemorrhage in a 26 year-old woman with idiopathic thrombocytopenic purpura Gavin Awerbuch and Reuven Sandyk Department ofNeurology, University ofArizona Health Sciences Center, Tucson, AZ. 85724, USA. Summary: Intracranial haemorrhage (ICH), a rare complication of idiopathic thrombocytopenic purpura (ITP), described only once previously in an adult, is usually fatal. We report a previously healthy 26 year old woman with chronic ITP in whom spontaneous ICH developed. The eventual favourable outcome in this case despite severe initial neurological deficit makes this case unusual. The importance of aggressive management in an ITP associated ICH is stressed and a plan for management is suggested. Introduction Although relatively rare, intracranial haemorrhage of 5.7 g/dl, white blood count of 15.5 x I09/l with a (ICH) is the most serious complication of idiopathic normal differential and a platelet count of 6.0 x 109/l, thrombocytopenic purpura (ITP) and is the leading reticulocyte count was 3.2%. The prothrombin time, reported cause ofdeath.'`3 In children, nearly 20 cases partial thromboplastin time, thrombin time, fibrin- Protected by copyright. of acute ITP complicated by ICH have been reported. ogen, fibrin monomers, and fibrin split products were Previous reports have alluded to ICH associated with all normal. An electroencephalogram (EEG), gallium ITP in adults,4`7 but ICH has been documented only scan of the abdomen, chest X-ray, and computerized once in adults.8 We report the occurrence of an axial tomography (CT scan) of the head were normal.
[Show full text]
Cerebral Venous Thrombosis After Intravenous Immunoglobulin Therapy in Immune Thrombocytopenic Purpura
Case Report Cerebral Venous Thrombosis after Intravenous Immunoglobulin Therapy in Immune Thrombocytopenic Purpura Joe James, P. V. Shiji, Chandni Radhakrishnan Department of Internal Medicine, Government Medical College, Kozhikode, Kerala, India Abstract A common misconception is that immune thrombocytopenic purpura (ITP) causes only bleeding diathesis. From this case vignette of a young male with ITP who had cerebral venous thrombosis, we highlight the importance of considering venous thrombosis in such patients when they present with focal cerebral signs. Keywords: Immune thrombocytopenic purpura, intravenous immunoglobulin, venous thrombosis 3 INTRODUCTION blood cell count of 21,800/mm with 84% neutrophils, 12% lymphocytes, and 4% mixed cells; hemoglobin of 11.2 g/dl; and Immune thrombocytopenic purpura (ITP) is a disorder platelet count of 65,000/mm3. Serum sodium was 136 mEq/L, characterized by autoimmune destruction of platelets, potassium 3.9 mEq/L, calcium 9.1 mg/dL, and plasma glucose which commonly presents as bleeding diathesis. However, 105 mg/dL. Serum creatinine was 1.1 mg/dL, total bilirubin thromboembolic complications can also occur in ITP. Here, was 1.5 mg/dL, and alanine aminotransferase was 30 IU. we describe a case of ITP who presented with cerebral venous International normalized ratio was 1.03 and activated partial thrombosis (CVT) after treatment with high‑dose intravenous thromboplastin time was 31.3 (reference <28). Anti‑nucleosome immunoglobulin (IVIg). antibody, anti ds‑DNA, C3 and C4 levels were normal. HIV, HBsAg, and HCV serology were negative. Computed CASE REPORT tomography (CT) of the head showed a small intraparenchymal A 26‑year‑old‑male with a history of ITP, presented with hematoma in the right frontal lobe [Figure 1a].
[Show full text]
Protein C 결핍에서 발생한 소모성 응고질환으로 인한 뇌내출혈로 야기된 뇌성마비 환자에 대한 증례기록 연세대학교 의과대학 세브란스병원 재활의학과1, 소아청소년과2 조유나1・이영 목 2・박 은 숙 1・최 자 영 1・박 천 웅 1・나 동 욱 1
J Korean Child Neurol Soc 2017;25(1):44-47 Case report pISSN 1226-6884•eISSN 2383-8973 Protein C 결핍에서 발생한 소모성 응고질환으로 인한 뇌내출혈로 야기된 뇌성마비 환자에 대한 증례기록 연세대학교 의과대학 세브란스병원 재활의학과1, 소아청소년과2 조유나1・이영 목 2・박 은 숙 1・최 자 영 1・박 천 웅 1・나 동 욱 1 Cerebral Palsy due to Intracranial Hemorrhage Yoona Cho, MD1, Young-Mock Lee, MD2, Eun Sook Park, MD1, Ja Young Choi, MD1, Chunung Caused by Consumptive Coagulopathy in Protein C Park, MD1, Dong-wook Rha, MD, PhD1 Deficiency: A Case Report 1Department and Research Institute of Rehabi- Protein C (PROC) is a potent anticoagulant inactivating coagulation factors Va and litation Medicine, 2Department of Pediatrics, VIIIa. PROC deficiency is very rare condition inherited as an autosomal dominant Gangnam Severance Hospital, Yonsei University or recessive trait, and associated with various thromboembolic and ischemic College of Medicine, Seoul, Korea conditions. Moreover, severe form of PROC deficiency can cause fatal hemorrhagic complications due to consumptive coagulopathy. We reported two children with Submitted: 24 August, 2016 Revised: 13 September, 2016 hemorrhagic stroke who were diagnosed as severe PROC deficiency caused by two Accepted: 13 September, 2016 different types of compound heterozygous PROC gene mutations. We described results of laboratory tests, genetic analysis, brain magnetic resonance images, and Correspondence to Dong-wook Rha, MD, PhD functional outcomes. Both children received prophylactic anticoagulation therapy Department and Research Institute of Rehabilitation, and presented with purple-colored skin lesions during rehabilitation. Purpura Medicine Yonsei University College of Medicine, Severance Rehabilitation Hospital, BioMechanics and fulminans caused by insufficient anticoagulation should be differentiated from Robotic Rehabilitation Laboratory, 50-1 Yonsei-ro hematoma caused by excessive anticoagulation therapy in these children.
[Show full text]
Thrombocytopenia and Intracranial Venous Sinus Thrombosis After “COVID-19 Vaccine Astrazeneca” Exposure
Journal of Clinical Medicine Article Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” Exposure Marc E. Wolf 1,2 , Beate Luz 3, Ludwig Niehaus 4 , Pervinder Bhogal 5, Hansjörg Bäzner 1,2 and Hans Henkes 6,7,* 1 Neurologische Klinik, Klinikum Stuttgart, D-70174 Stuttgart, Germany; [email protected] (M.E.W.); [email protected] (H.B.) 2 Department of Neurology, Universitätsmedizin Mannheim, University of Heidelberg, D-68167 Mannheim, Germany 3 Zentralinstitut für Transfusionsmedizin und Blutspendedienst, Klinikum Stuttgart, D-70174 Stuttgart, Germany; [email protected] 4 Neurologie, Rems-Murr-Klinikum Winnenden, D-71364 Winnenden, Germany; [email protected] 5 Department of Interventional Neuroradiology, The Royal London Hospital, Barts NHS Trust, London E1 1FR, UK; [email protected] 6 Neuroradiologische Klinik, Klinikum Stuttgart, D-70174 Stuttgart, Germany 7 Medical Faculty, University Duisburg-Essen, D-47057 Duisburg, Germany * Correspondence: [email protected]; Fax: +49-711-278-345-09 Abstract: Background: As of 8 April 2021, a total of 2.9 million people have died with or from the coronavirus infection causing COVID-19 (Corona Virus Disease 2019). On 29 January 2021, the European Medicines Agency (EMA) approved a COVID-19 vaccine developed by Oxford University Citation: Wolf, M.E.; Luz, B.; and AstraZeneca (AZD1222, ChAdOx1 nCoV-19, COVID-19 vaccine AstraZeneca, Vaxzevria, Cov- Niehaus, L.; Bhogal, P.; Bäzner, H.; ishield). While the vaccine prevents severe course of and death from COVID-19, the observation of Henkes, H. Thrombocytopenia and pulmonary, abdominal, and intracranial venous thromboembolic events has raised concerns. Objec- Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine tive: To describe the clinical manifestations and the concerning management of patients with cranial AstraZeneca” Exposure.
[Show full text]
Methods and Material
THE MAMMOGRAPHIC AND SONOGRAPHIC FEATURES OF MALE BREAST DISEASES AT KING HUSSEIN MEDICAL CENTRE Amal A. Smadi, MD, JBR* ABSTRACT Objectives: To describe the mammographic and sonographic features of male breast diseases, and to correlate the radiological, cytological and histopathological diagnoses. Methods: This is a retrospective descriptive study that was conducted at King Hussein Medical Centre, Amman, Jordan between January 1st 2004 and December 31st 2007. The mammograms and breast ultrasounds of 88 symptomatic male patients were reviewed and analyzed. A total of 24 patients with unilateral breast masses underwent fine-needle aspiration, eight of them with suspected malignant lesions underwent further true cut biopsy and surgery. The radiological, cytological and histopathological diagnoses were correlated. Results: Sixty one (70%) patients had gynaecomastia, 15 (17%) had fatty breasts (pseudo-gynaecomastia), eight (9%) had primary breast carcinoma, two (2%) had lipomas, one (1%) had abscess, and one (1%) had hematoma. The characteristic radiological features were confirmed by fine-needle aspiration cytology in 16 patients and by both cytology and histopathology studies in eight cases. Conclusion: Radiological findings provide characteristic diagnostic appearances for certain important male breast diseases. The radiological features can be accurately correlated with pathological diagnosis. Key words: Male Breast, Mammography, Sonography JRMS March 2010; 17(1): 57-61 Introduction in diagnosis can result from ignorance of the Breast disorders in males can be distressing and existence of breast cancer in males, and this may patients often feel embarrassed and anxious.(1) In adversely affect prognosis. In evaluating the our community a male patient with breast clinically abnormal male breast, mammography and ultrasound are essential, and should be performed enlargement or mass will be very reluctant to seek (2) medical advice as this might be considered a social along with the physical clinical examination.
[Show full text]